What is she best known for?
The fields of study she is best known for:
Her primary scientific interests are in Cancer, Antigen, Immunology, Stereochemistry and Cancer research.
In general Cancer, her work in Breast cancer and Cancer treatment is often linked to Protocol design linking many areas of study.
Her study focuses on the intersection of Antigen and fields such as Immune system with connections in the field of Antibody.
Her research investigates the connection between Immunology and topics such as Telomerase reverse transcriptase that intersect with problems in Cellular immunity.
Her Stereochemistry research includes themes of Tryptophan synthase, Biochemistry, Serine and Active site.
Her research in Cancer research focuses on subjects like Cancer cell, which are connected to CD44, Interleukin 4, Cell adhesion, Metastasis and CCL18.
Her most cited work include:
- Molecular Definition of Breast Tumor Heterogeneity (1116 citations)
- The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors (624 citations)
- CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3 (358 citations)
What are the main themes of her work throughout her whole career to date?
Karen S. Anderson mainly investigates Breast cancer, Internal medicine, Cancer, Immunology and Antigen.
Within one scientific family, Karen S. Anderson focuses on topics pertaining to Cancer research under Breast cancer, and may sometimes address concerns connected to Cell.
In her work, Neoadjuvant therapy is strongly intertwined with Oncology, which is a subfield of Internal medicine.
Her biological study spans a wide range of topics, including Molecular biology and Pathology.
Her work deals with themes such as Biochemistry and Enzyme, which intersect with Molecular biology.
Her Antigen research is multidisciplinary, relying on both Autoantibody, Antibody, Cytotoxic T cell and Protein microarray.
She most often published in these fields:
- Breast cancer (19.15%)
- Internal medicine (18.31%)
- Cancer (17.75%)
What were the highlights of her more recent work (between 2018-2021)?
- Breast cancer (19.15%)
- Internal medicine (18.31%)
- Cancer research (14.37%)
In recent papers she was focusing on the following fields of study:
Her primary areas of study are Breast cancer, Internal medicine, Cancer research, Oncology and Disease.
Her Breast cancer research is classified as research in Cancer.
The study incorporates disciplines such as Myxoma virus and Multiplicity of infection in addition to Cancer.
Her Cancer research study integrates concerns from other disciplines, such as Duodenal Carcinoma, DNA mismatch repair, Renal cell carcinoma and Immunotherapy.
She focuses mostly in the field of Immunotherapy, narrowing it down to matters related to Surgical oncology and, in some cases, Epitope.
Karen S. Anderson has researched Oncology in several fields, including Neoadjuvant therapy, Neo adjuvant, Autoantibody, Mammography screening and Early detection.
Between 2018 and 2021, her most popular works were:
- Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer (58 citations)
- Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer (58 citations)
- Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes (48 citations)
In her most recent research, the most cited papers focused on:
Karen S. Anderson spends much of her time researching Breast cancer, Internal medicine, Epitope, Oncology and Genetics.
Karen S. Anderson is interested in Breast biopsy, which is a branch of Breast cancer.
Her Internal medicine research integrates issues from Exome sequencing and Autoantibody.
Karen S. Anderson has included themes like Virology, T cell, CD8, Immunogenicity and Human leukocyte antigen in her Epitope study.
The Oncology study combines topics in areas such as Neoadjuvant therapy, Breast imaging, Disease, Biomarker and Bi rads 3.
Her Disease research includes elements of Neoplasm, Cancer, Circulating tumor DNA and Complete response.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
